Upton Votes to Lower Prescription Drug Costs
Two bipartisan bills advance that remove barriers preventing patients from paying lowest possible price for prescription drugs
U.S. Rep. Fred Upton, R-St. Joseph, today joined colleagues in the U.S. House of Representatives in voting to advance S. 2554, the Patient Right to Know Drug Prices Act and S. 2553, the Know the Lowest Price Act of 2018. Upton released the following statement:
“Today we took bipartisan action to lower drug costs for patients. Folks here in Southwest Michigan should have access to transparent pricing information. In other words, your pharmacist should be able to tell you if there is a cheaper way to get your prescriptions filled. These two bipartisan bills will remove those barriers preventing patients from paying the lowest possible prices for the prescription drugs they need.”
The Patient Right to Know Drug Prices Act was sponsored by U.S. Senator Susan Collins, R-Maine, and would prohibit an insurer or pharmacy manager from restricting a pharmacy’s ability to provide drug price information to a plan enrollee when there is a difference between the cost of the drug under the plan and the cost of the drug when purchased without insurance. This bill would apply to plans offered through insurance exchanges and by private employers.
The Know the Lowest Price Act was sponsored by U.S. Senator Debbie Stabenow, D-Michigan, and would provide the same protections for individuals covered by Medicare Advantage and Medicare Part D plans.